A commitment to spend hundreds of millions of dollars on developing obesity drugs is the latest move by a Japanese drugmaker to shore up growth by expanding abroad Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,